Metabolic Checkpoints in CD8⁺ T Cells within the Tumor Microenvironment: A Comprehensive Review and Emerging Insights

Area of Science:

• Immunology
• Cancer Biology
• Metabolic Research

Background:

• Cancer is increasingly recognized as a metabolic disease.
• Metabolic reprogramming within the tumor microenvironment (TME) influences tumor development.
• CD8+ T cells are critical mediators of anti-tumor immunity, undergoing metabolic changes.

Purpose of the Study:

• To review the anti-tumor functions and metabolic profiles of CD8+ T cells in the TME.
• To elucidate the roles of key metabolites and metabolic checkpoints in CD8+ T cell differentiation and function.
• To explore clinical applications of targeting metabolic checkpoints for cancer immunotherapy.

Main Methods:

• Literature review focusing on CD8+ T cell metabolism in the TME.
• Analysis of nutrient metabolism (glucose, lipids, amino acids) in CD8+ T cells.
• Discussion of metabolic checkpoints and their epigenetic impact on T cells.

Main Results:

• CD8+ T cells exhibit distinct metabolic profiles at different differentiation stages within the TME.
• Metabolites and metabolic checkpoints significantly shape CD8+ T cell differentiation, effector functions, and immune responses.
• Heterogeneity exists in the effects of metabolic checkpoints, suggesting tailored therapeutic strategies.

Conclusions:

• Metabolic reprogramming is a key factor in CD8+ T cell-mediated anti-tumor immunity.
• Understanding CD8+ T cell metabolism offers potential for novel cancer immunotherapy strategies.
• Targeting metabolic checkpoints may enhance the efficacy of T cell-based cancer treatments.